Edition:
India

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

116.97USD
24 Mar 2017
Change (% chg)

$0.17 (+0.15%)
Prev Close
$116.80
Open
$116.99
Day's High
$118.26
Day's Low
$116.91
Volume
8,166
Avg. Vol
26,547
52-wk High
$152.30
52-wk Low
$92.28

TARO.N

Chart for TARO.N

About

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical... (more)

Overall

Beta: 0.78
Market Cap(Mil.): $4,799.53
Shares Outstanding(Mil.): 41.03
Dividend: --
Yield (%): --

Financials

  TARO.N Industry Sector
P/E (TTM): 10.00 29.18 29.98
EPS (TTM): 11.69 -- --
ROI: 25.91 13.62 13.13
ROE: 25.96 14.52 14.27

BRIEF-Bellus Health to sell subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals

* Press release - Bellus Health announces the sale of subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals

17 Mar 2017

India's Sun Pharma Q3 profit falls nearly 5 pct; below estimates

MUMBAI, Feb 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd's third-quarter profit fell below analysts' estimates due to slower sales in the United States, its largest market.

14 Feb 2017

BRIEF-Taro posts quarterly sales of $220.4 million

* Taro Pharmaceutical Industries Ltd qtrly net income per ordinary share from continuing operations attributable to taro $3.42 Source text for Eikon: Further company coverage:

10 Feb 2017

BRIEF-Taro Pharmaceutical Industries names Uday Baldota CEO

* Taro Pharmaceutical Industries Ltd- Uday Baldota as chief executive officer

22 Nov 2016

BRIEF-Taro Pharmaceutical Industries qtrly loss per share $0.00

* Taro Pharmaceutical Industries Ltd - qtrly loss per share $0.00

09 Nov 2016

BRIEF-Taro appoints new chief financial officer

* Appointment of Mariano Balaguer as vice president, CFO and chief accounting officer, effective today Source text for Eikon: Further company coverage:

04 Oct 2016

More From Around the Web

Earnings vs. Estimates